• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

妊娠期间复发性转移性输卵管癌

Recurrent metastatic fallopian tube carcinoma in pregnancy.

作者信息

Adolph A, Le T, Khan K, Biem S

机构信息

Department Obstetrics, Gynecology and Reproductive Sciences, Royal University Hospital, Saskatoon, Saskatchewan, S7N 0W0, Canada.

出版信息

Gynecol Oncol. 2001 Apr;81(1):110-2. doi: 10.1006/gyno.2000.6097.

DOI:10.1006/gyno.2000.6097
PMID:11277660
Abstract

BACKGROUND

Fallopian tube cancer is the rarest of all gynecologic cancers. An extensive literature search on Medline reveals no previous case reports of fallopian tube carcinoma in association with a term pregnancy.

CASE

A woman with surgical stage IIB fallopian tube carcinoma was treated with limited staging laparotomy, as per the patient's fertility wishes, followed by adjuvant cis-platinum and paclitaxel (Taxol). One year following chemotherapy, she conceived. She was noted to have an asymptomatic intraabdominal recurrence at 16 weeks. The patient completed 37 weeks of pregnancy without further therapy according to her wishes. She subsequently underwent a cesarean section with optimal tumor reduction surgery. Carboplatin and paclitaxel were reinstituted, achieving partial response. She is presently alive with stable disease status 6 months after completing her salvage chemotherapy.

CONCLUSION

This is the first case report of recurrent fallopian tube cancer in pregnancy.

摘要

背景

输卵管癌是所有妇科癌症中最罕见的。对医学在线数据库(Medline)进行广泛文献检索后发现,此前尚无输卵管癌合并足月妊娠的病例报告。

病例

一名患有手术分期为IIB期输卵管癌的女性,根据患者的生育意愿,接受了有限分期剖腹探查术,随后进行辅助性顺铂和紫杉醇(泰素)治疗。化疗一年后,她怀孕了。在孕16周时发现她有无症状的腹腔内复发。患者按照自己的意愿在未接受进一步治疗的情况下完成了37周的妊娠。随后她接受了剖宫产及最佳肿瘤减灭术。重新使用卡铂和紫杉醇治疗后,病情获得部分缓解。在完成挽救性化疗6个月后,她目前仍存活,病情稳定。

结论

这是首例妊娠合并复发性输卵管癌的病例报告。

相似文献

1
Recurrent metastatic fallopian tube carcinoma in pregnancy.妊娠期间复发性转移性输卵管癌
Gynecol Oncol. 2001 Apr;81(1):110-2. doi: 10.1006/gyno.2000.6097.
2
Paclitaxel and platinum chemotherapy for ovarian carcinoma during pregnancy.孕期卵巢癌的紫杉醇与铂类化疗
Gynecol Oncol. 2001 Dec;83(3):599-600. doi: 10.1006/gyno.2001.6439.
3
Patterns of recurrence in advanced epithelial ovarian, fallopian tube and peritoneal cancers treated with intraperitoneal chemotherapy.高级上皮性卵巢癌、输卵管癌和腹膜癌经腹腔化疗后的复发模式。
Gynecol Oncol. 2012 Oct;127(1):51-4. doi: 10.1016/j.ygyno.2012.05.026. Epub 2012 May 30.
4
Long-term survival of a patient with fallopian tube cancer presenting with a supraclavicular mass.一名以锁骨上肿块为表现的输卵管癌患者的长期生存情况。
Anticancer Res. 2000 Nov-Dec;20(6C):4801-2.
5
Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study.输卵管癌患者治疗失败与生存情况分析:一项合作特别工作组(CTF)研究
Gynecol Oncol. 2001 May;81(2):150-9. doi: 10.1006/gyno.2001.6134.
6
Sister Mary Joseph's nodule as the first presenting sign of primary fallopian tube adenocarcinoma.玛丽·约瑟夫修女结节作为原发性输卵管腺癌的首发体征
J Minim Invasive Gynecol. 2006 May-Jun;13(3):234-6. doi: 10.1016/j.jmig.2006.01.009.
7
The efficacy of adjuvant platinum-based chemotherapy in Stage I uterine papillary serous carcinoma (UPSC).辅助铂类化疗在Ⅰ期子宫浆液性乳头状癌(UPSC)中的疗效。
Gynecol Oncol. 2005 Dec;99(3):557-63. doi: 10.1016/j.ygyno.2005.07.104. Epub 2005 Sep 8.
8
Fallopian tube carcinoma presenting with a brain metastasis.以脑转移为表现的输卵管癌。
Gynecol Oncol. 2002 May;85(2):372-5. doi: 10.1006/gyno.2002.6595.
9
Ovarian carcinosarcomas: clinicopathological prognostic factors and evaluation of chemotherapy regimens containing platinum.卵巢癌肉瘤:临床病理预后因素及含铂化疗方案的评估
Gynecol Oncol. 2008 Jan;108(1):136-40. doi: 10.1016/j.ygyno.2007.09.003. Epub 2007 Oct 23.
10
Paclitaxel- and platinum-based postoperative chemotherapy for primary fallopian tube carcinoma: a single institution experience.原发性输卵管癌的紫杉醇和铂类术后化疗:单机构经验
Oncology. 2008;75(1-2):42-8. doi: 10.1159/000151668. Epub 2008 Aug 26.